James Porter
Chief Executive Officer chez NUVALENT, INC.
Fortune : 14 M $ au 31/03/2024
Profil
James R.
Porter is currently the President, Chief Executive Officer & Director at Nuvalent, Inc. Previously, he worked as the Vice President-Product Development at Infinity Pharmaceuticals, Inc. from 2002 to 2016.
He received his undergraduate degree from the College of the Holy Cross (Massachusetts) and his doctorate from Boston College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVALENT, INC. CLASS A
0,32% | 05/01/2024 | 188 113 ( 0,32% ) | 14 M $ | 31/03/2024 |
Postes actifs de James Porter
| Sociétés | Poste | Début |
|---|---|---|
| NUVALENT, INC. | Chief Executive Officer | 01/01/2017 |
Anciens postes connus de James Porter
| Sociétés | Poste | Fin |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2016 |
Formation de James Porter
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| Boston College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Nuvalent, Inc. |
